<!DOCTYPE html>
<html lang="en">
    <head>
        <meta name="DC.IDENTIFIER" content="http://dx.doi.org/10.17917/SA6R-9D63" scheme="DCTERMS.UI"><title>caNanoLab DOI Landing page</title>
        <style>
            h1 { text-align: center;}
            h2 { text-align: left;}
            table { border: 1px solid #dddddd; text-align: left; padding: 8px }
            td, th { border: 1px solid #dddddd; text-align: left; padding: 8px }
            tr:nth-child(even) { background-color: #dddddd }
        </style>
    </head><body><img src="./assets/images/crdc-logo.svg" alt="CRDC General Commons Logo"><h1> caNanoLab DOI </h1><hr><p><b>Protocol Type:</b> physico-chemical assay</p><p><b>Protocol Name:</b> NIST-NCL Joint Assay Protocol, PCC-8: Determination of Gold in Rat Tissue with Inductively Coupled Plasma Mass Spectrometry</p><p><b>Protocol Abbreviation:</b> PCC-8</p><p><b>Protocol Version:</b> 1.1<hr><p><b>DOI:</b> <a href = http://dx.doi.org/10.17917/SA6R-9D63>http://dx.doi.org/10.17917/SA6R-9D63</a></p><p><b>Protocol File:</b> protocols/20240410_16-15-31-230_NCL_Method_PCC-8.pdf<p><b>File Title:</b> PCC-8</p><p><b>Description:</b></b> A new class of pharmaceutical candidate based on gold nanoparticles has entered the small animal phase of clinical study. The content of gold in the blood and tissue of study animals must be determined. This technical procedure defines the analytical protocols for the determination of gold in the tissues of rats used in a clinical study.<hr><p><b>Resource Type:</b>  Protocol</p><p><b>Data Access:</b> <a href =https://general.datacommons.cancer.gov/#/data>https://general.datacommons.cancer.gov/#/data</a><p></body></html>